Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE OpenBruce E. Sands, Chinyu Su, Julián Panés et al.|Alimentary Pharmacology & Therapeutics|2019Cited by 85
905 - Efficacy and Safety of Tofacitinib Retreatment for Ulcerative Colitis after Treatment Interruption: Results from the Octave Clinical TrialsJulián Panés, Chinyu Su, Brian Bressler et al.|Gastroenterology|2018Cited by 6
P685 Improvement in patient-reported Inflammatory Bowel Disease Questionnaire outcomes, and relationship with disease activity, in tofacitinib-treated patients with ulcerative colitis: Data from the OCTAVE clinical trialsMarla C. Dubinsky, Chinyu Su, Deborah Woodworth et al.|Journal of Crohn s and Colitis|2019Cited by 3